Drug intelligence / Profile preview

CKD-380

Development stage: Preclinical
Modality: Small Molecules
Administration: Oral

Overview

CKD-380 is a pharmaceutical drug under investigation for the treatment of Type II Diabetes Mellitus. It is formulated as a 10mg tablet and is currently being evaluated in a clinical study to compare its pharmacokinetic characteristics and safety against D308 10mg in healthy male adults. The specific mechanism of action for CKD-380 has not been disclosed in the available information.

Beyond the preview

Go deeper on CKD-380.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CKD-380.